An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - PubMed (original) (raw)
Observational Study
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Lucio Verdoni et al. Lancet. 2020.
Abstract
Background: The Bergamo province, which is extensively affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic, is a natural observatory of virus manifestations in the general population. In the past month we recorded an outbreak of Kawasaki disease; we aimed to evaluate incidence and features of patients with Kawasaki-like disease diagnosed during the SARS-CoV-2 epidemic.
Methods: All patients diagnosed with a Kawasaki-like disease at our centre in the past 5 years were divided according to symptomatic presentation before (group 1) or after (group 2) the beginning of the SARS-CoV-2 epidemic. Kawasaki- like presentations were managed as Kawasaki disease according to the American Heart Association indications. Kawasaki disease shock syndrome (KDSS) was defined by presence of circulatory dysfunction, and macrophage activation syndrome (MAS) by the Paediatric Rheumatology International Trials Organisation criteria. Current or previous infection was sought by reverse-transcriptase quantitative PCR in nasopharyngeal and oropharyngeal swabs, and by serological qualitative test detecting SARS-CoV-2 IgM and IgG, respectively.
Findings: Group 1 comprised 19 patients (seven boys, 12 girls; aged 3·0 years [SD 2·5]) diagnosed between Jan 1, 2015, and Feb 17, 2020. Group 2 included ten patients (seven boys, three girls; aged 7·5 years [SD 3·5]) diagnosed between Feb 18 and April 20, 2020; eight of ten were positive for IgG or IgM, or both. The two groups differed in disease incidence (group 1 vs group 2, 0·3 vs ten per month), mean age (3·0 vs 7·5 years), cardiac involvement (two of 19 vs six of ten), KDSS (zero of 19 vs five of ten), MAS (zero of 19 vs five of ten), and need for adjunctive steroid treatment (three of 19 vs eight of ten; all p<0·01).
Interpretation: In the past month we found a 30-fold increased incidence of Kawasaki-like disease. Children diagnosed after the SARS-CoV-2 epidemic began showed evidence of immune response to the virus, were older, had a higher rate of cardiac involvement, and features of MAS. The SARS-CoV-2 epidemic was associated with high incidence of a severe form of Kawasaki disease. A similar outbreak of Kawasaki-like disease is expected in countries involved in the SARS-CoV-2 epidemic.
Funding: None.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Figures
Figure
Incidence of Kawasaki disease in the study period and in the past 5 years (A) Frequency of Kawasaki disease at the paediatric emergency department of Hospital Papa Giovanni XXIII of Bergamo, Italy, in the past 5 years, by case severity. (B) Number of patients presenting to the paediatric emergency department during the severe acute respiratory syndrome coronavirus 2 epidemic, and date of presentation of ten patients with Kawasaki-like disease (indicated by asterisks).
Comment in
- Autoimmune and inflammatory diseases following COVID-19.
Galeotti C, Bayry J. Galeotti C, et al. Nat Rev Rheumatol. 2020 Aug;16(8):413-414. doi: 10.1038/s41584-020-0448-7. Nat Rev Rheumatol. 2020. PMID: 32499548 Free PMC article. - Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19.
Buonsenso D, Di Sante G, Sali M; CURE COVID-19 Study Group. Buonsenso D, et al. Pediatr Infect Dis J. 2020 Aug;39(8):e213-e215. doi: 10.1097/INF.0000000000002802. Pediatr Infect Dis J. 2020. PMID: 32677813 No abstract available. - Association between COVID-19 and Kawasaki-like disease in children is a topic that needs further investigation.
Moradi S, Radgoodarzi M. Moradi S, et al. Evid Based Nurs. 2021 Apr;24(2):35. doi: 10.1136/ebnurs-2020-103319. Epub 2020 Dec 1. Evid Based Nurs. 2021. PMID: 33262169 No abstract available. - COVID-19-induced Kawasaki disease.
Carvalho T. Carvalho T. Nat Med. 2020 Dec;26(12):1807. doi: 10.1038/s41591-020-01163-y. Nat Med. 2020. PMID: 33288939 No abstract available.
Similar articles
- Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S, Danis K, Chomton M, Maurice L, Le Bourgeois F, Caseris M, Gaschignard J, Poline J, Cohen R, Titomanlio L, Faye A, Melki I, Meinzer U. Ouldali N, et al. Lancet Child Adolesc Health. 2020 Sep;4(9):662-668. doi: 10.1016/S2352-4642(20)30175-9. Epub 2020 Jul 2. Lancet Child Adolesc Health. 2020. PMID: 32622376 Free PMC article. - An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?
Cavallo F, Chiarelli F. Cavallo F, et al. Acta Biomed. 2020 Sep 7;91(3):e2020015. doi: 10.23750/abm.v91i3.10305. Acta Biomed. 2020. PMID: 32921711 Free PMC article. Review. - Kawasaki disease epidemic: pitfalls.
Gallizzi R, Corsello G, Pajno GB. Gallizzi R, et al. Ital J Pediatr. 2020 Aug 27;46(1):121. doi: 10.1186/s13052-020-00887-4. Ital J Pediatr. 2020. PMID: 32854742 Free PMC article. - Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, Meini A, Sottile R, Caorsi R, Zuccotti G, Fabi M, Montin D, Meneghel A, Consolaro A, Dellepiane RM, Maggio MC, La Torre F, Marchesi A, Simonini G, Villani A, Cimaz R, Ravelli A, Taddio A; Rheumatology Study Group of the Italian Pediatric Society. Cattalini M, et al. Pediatr Rheumatol Online J. 2021 Mar 16;19(1):29. doi: 10.1186/s12969-021-00511-7. Pediatr Rheumatol Online J. 2021. PMID: 33726806 Free PMC article. - The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic.
Lami F, Scalabrini I, Lucaccioni L, Iughetti L. Lami F, et al. Acta Biomed. 2020 Sep 7;91(3):e2020034. doi: 10.23750/abm.v91i3.10360. Acta Biomed. 2020. PMID: 32921728 Free PMC article. Review.
Cited by
- Role of Xenosialylation in Post-Infectious and Post-Vaccination Complications, Including Covid-19 and Anti-SARS-CoV-2 Vaccination.
Carnevali F, Mangiaterra S, Rossi G. Carnevali F, et al. J Inflamm Res. 2024 Nov 7;17:8385-8394. doi: 10.2147/JIR.S471093. eCollection 2024. J Inflamm Res. 2024. PMID: 39529999 Free PMC article. - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19 Infection in Morocco.
Amenzoui N, Zouiter S, Nassid M, Kholaiq H, Belkhou I, Benhsaien I, Ailal F, Adnane F, Jouhadi Z, Bousfiha AA. Amenzoui N, et al. Glob Pediatr Health. 2024 Oct 28;11:2333794X241286772. doi: 10.1177/2333794X241286772. eCollection 2024. Glob Pediatr Health. 2024. PMID: 39493464 Free PMC article. - A Comparison of Kawasaki Disease during the SARS-CoV-2 Pandemic with Multisystem Inflammatory Syndrome in Children.
Tunçer T, Varol F. Tunçer T, et al. Children (Basel). 2024 Sep 28;11(10):1185. doi: 10.3390/children11101185. Children (Basel). 2024. PMID: 39457150 Free PMC article. - Exploring the Therapeutic Potential of Vitamin D in Kawasaki Disease and Its Interplay with the COVID-19.
Visuddho V, Welliam Y, Maitri Aldian F, Tri Arif Sampurna M, Irzaldy A. Visuddho V, et al. Turk Arch Pediatr. 2024 Sep 2;59(5):432-439. doi: 10.5152/TurkArchPediatr.2024.24141. Turk Arch Pediatr. 2024. PMID: 39439407 Free PMC article. - Kawasaki disease before and during the COVID-19 pandemic: a single-center comparative study in Switzerland.
Epitaux J, Sekarski N, Bressieux-Degueldre S. Epitaux J, et al. BMC Pediatr. 2024 Oct 8;24(1):637. doi: 10.1186/s12887-024-05115-0. BMC Pediatr. 2024. PMID: 39379864 Free PMC article.
References
- Ministero della Salute Nuovo coronavirus: cosa c'è da sapere. http://www.salute.gov.it/portale/nuovocoronavirus/
- Flaxman S, Mishra S, Gandy A. Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous